tykhr
sign in
free sign up
NewAmsterdam Pharma Company N.V. Ordinary Shares
Biotechnology
Healthcare
NAMS
113 M shares
NASDAQ US
traded
23 Sep 2025
listed
no
open
26.78
52 week high
27.05
high
27.21
52 week low
0.00
low
26.52
growth
67.53 %
previous Close
27.05
P/E ratio
market cap
2.85 B
div yield
0
usd
Jun 2025
qoq
revenue
19.15 M
542.88 %
net incoming
-17.36 M
56.07 %
eps
0.00 %
50.27 %
eps surprise
65.91 %
net profit margin
-90.70 %
1236.00 %
operating incoming
-35.64 M
48.30 %
net change in cash
-184.56 M
-691.30 %
cash on hand
564 M
-24.66 %
cost of revenue
0.00 %
top